Evaluation and Management of Febrile Infants 28-60 Days Old
For well-appearing febrile infants aged 28-60 days, obtain urinalysis (by catheterization or suprapubic aspiration), blood culture, and consider inflammatory markers (procalcitonin, ANC) to guide management; lumbar puncture is not routinely required if inflammatory markers are normal, but use shared decision-making with caregivers when markers are abnormal or unavailable. 1
Diagnostic Workup
Essential Testing
Urinalysis and urine culture: Obtain via catheterization or suprapubic aspiration (not bag collection for culture) 1
- Circumcised males have <1% UTI risk and may be exempted 1
- If urinalysis positive (leukocyte esterase or nitrites), initiate empiric antibiotics
Blood culture: Obtain in all febrile infants 28-60 days 1
Inflammatory markers (IM): Procalcitonin and/or absolute neutrophil count help risk-stratify 1
Lumbar Puncture Decision-Making
CSF analysis is NOT routinely required for 29-60 day infants if inflammatory markers are normal 1. However:
Perform LP if:
May defer LP if:
- All inflammatory markers normal
- Urinalysis negative
- Infant remains well-appearing
- Family understands risks and can return for reassessment 1
Antibiotic Management
When to Start Antibiotics
Initiate parenteral antibiotics if ANY of the following 1:
- CSF analysis suggests bacterial meningitis (if LP performed)
- Urinalysis is positive (LE or nitrites)
- Any inflammatory marker is abnormal (even with normal UA and CSF)
May withhold antibiotics if ALL of the following 1:
- CSF normal or enterovirus-positive (if obtained)
- Urinalysis negative
- All inflammatory markers normal
- Risk of bacteremia <0.1% (number needed to treat >300)
Antibiotic Regimens for 29-60 Day Infants
| Clinical Scenario | Antibiotic Choice |
|---|---|
| UTI (positive UA) | Ceftriaxone 50 mg/kg IV/IM once daily OR oral therapy (cephalexin 50-100 mg/kg/day divided q6h or cefixime 8 mg/kg once daily) [1] |
| No focus identified | Ceftriaxone 50 mg/kg IV/IM once daily [1] |
| Bacterial meningitis | Ceftriaxone 100 mg/kg/day IV (once daily or divided q12h) OR Ceftazidime 150 mg/kg/day divided q8h PLUS Vancomycin 60 mg/kg/day divided q8h [1] |
Critical caveat: Vancomycin is added empirically for meningitis due to resistant S. pneumoniae risk; discontinue if organism other than S. pneumoniae identified 1
Disposition
Hospitalization Criteria
Admit to hospital with neonatal-experienced staff if 1:
- CSF not obtained or uninterpretable
- CSF suggests bacterial meningitis
- Parenteral antibiotics initiated
- Difficulty feeding, vomiting, or decreased urine output requiring monitoring
Outpatient Management Acceptable If
- Urinalysis negative
- All inflammatory markers normal (if obtained)
- CSF normal (if obtained)
- Infant well-appearing
- Family can monitor and return within 24 hours 1
- Consider transportation vouchers for families with access barriers 1
Follow-Up and Antibiotic Duration
Discontinue Antibiotics When 1:
- All cultures negative at 24-36 hours
- Infant clinically well or improving (afebrile, feeding well)
- No other infection requiring treatment
Important timing: 15-18% of bacterial pathogens not detected by 24 hours; 5-7% require >36 hours for blood cultures, 6-15% for CSF 1
For Positive Cultures
- UTI with negative blood/CSF: May discharge on oral antibiotics if infant well-appearing 1
- Bacteremia or meningitis: Continue targeted IV therapy for duration appropriate to organism and clinical response 1
Common Pitfalls to Avoid
Do not rely on bagged urine specimens for culture - high contamination rate leads to false positives and unnecessary treatment 1
Do not assume viral testing excludes bacterial infection - while positive viral tests reduce SBI risk, co-infection occurs; maintain vigilance with abnormal inflammatory markers 2
Do not discharge without clear return precautions - 85% of bacteremia in well-appearing infants grows by 24 hours vs 93% in ill-appearing infants; delayed growth occurs 1
Do not use clinical appearance alone - only 58% of infants with bacteremia or meningitis appear clinically ill 2
Do not forget local antibiogram - resistance patterns vary; adjust empiric coverage accordingly 1